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Systematic review and meta-analysis
Neil Dolan1, Melanie Simmonds-Buckley1, Stephen Kellett*1,2 ,
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Objectives. This review sought to evaluate the effectiveness of the ‘Stress Control’
(SC) large psychoeducational 6-session group programme developed to increase access
to treatment for patients with anxiety and depression.
Design. Systematic review andmeta-analysis (Prospero registration:CRD42020173676).
Methods. Pre–post and post-treatment follow-up effect sizes were extracted and
synthesized in a randomeffectsmeta-analysis, and variations ineffect sizeswere investigated
via moderator analyses. Secondary analyses synthesized between-group effect sizes from
controlled studies containing comparator treatments and calculated the average dropout
rate. The quality of the meta-analysis was assessed using the GRADE approach.
Results. Nineteen studies with pre–post treatment outcomes were included. The
average group size was N = 39, and the average dropout rate was 34%. Pooled effect sizes
indicated moderate pre–post treatment reductions in anxiety (ES = 0.58; CI 0.41 to 0.75;
N = 5597; Z = 7.13; p < .001), moderate reductions in depression (ES = 0.62; CI 0.44 to
0.80; N = 5538, Z = 7.30; p < .001), and large reductions in global distress (ES = 0.86; CI
0.61 to 1.11; N = 591; Z = 7.41; p < .001). At follow-up, improvements in anxiety,
depression, and global distress were maintained. When SC was compared to active and
passive controls, outcomes were equivalent for anxiety (ES = 0.12, 95% CI0.25 to 0.49,
Z = 0.70; p = .482) and depression (ES = 0.15, 95% CI 0.24 to 0.54, Z = 0.84;
p = .401).
Conclusions. SC appears to be a clinically effective and durable low-intensity group
intervention that facilitates access to treatment for large patient numbers. However,
conclusions are limited by the low methodological quality of the evidence.
Practitioner points
 The stress control version of large group psychoeducation is appropriate and effective for mild-to-
moderate anxiety and depression
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 The evidence base for stress control is predominantly made up of practice-based studies
 Stress control needs to form one component of the overall offer made to patients presenting with
mild-to-moderate anxiety and depression
 The competencies required to deliver such groups need better specification
The high prevalence of depression and anxiety disorders raises the need for mental
health services to enable rapid access to evidence-based psychological interventions
(Delgadillo et al., 2016). There is clear evidence of patient preference for
psychological rather than pharmacological management of anxiety and depression
(McHugh, Whitton, Peckham, Welge, & Otto, 2013). However, complaints of lack of
access or long wait times for psychological treatment are commonplace (Turpin,
Richards, Hope, & Duffy, 2008). Enabling access to psychological interventions that
are both clinically effective and organizationally efficient is therefore critical (Khan,
Khan, Harez, Tu, & Kroenke, 2003; Layard et al., 2006). Services have responded to
this challenge by changing service design (and associated treatment options) to
improve access and throughput. This has most often been through implementing
stepped care approaches which are built on initially offering a low-intensity (LI)
intervention and stepping up to high-intensity interventions according to responsivity
and risk (Bower & Gilbody, 2005). Kellett, Bee, Aadahl, Headley, and Delgadillo
(2020) characterized the key features of low-intensity approaches as being delivered
by non-specialists, being psychoeducational in nature, delivered via a variety of
formats (e.g., in-person, in groups, via internet), creating low patient burden and
typically being based on cognitive behavioural theory (CBT). LI interventions are
based on CBT due to its well-established evidence base for the treatment for anxiety
and depression (Cuijpers et al., 2013; Hofmann & Smits, 2008).
A prime example of the low-intensity, low-contact, and high-volume treatment
approach is the Stress Control (SC) programme, which was explicitly designed to meet
the access-delivery challenge in primary care (Brown, Elliott, & Butler, 2006; White &
Kennan, 1990). The SC programme does this by adopting a didactic and large group
treatment approach that teaches anxiety and depression management skills. SC is
delivered over six two-hour sessions in community settings (e.g., health centres, public
conference rooms, gyms, and hotels) in a night-class style format facilitated by two
non-specialist facilitators. The large group psychoeducational format means that SC
epitomizes the low patient contact to high patient volume delivery approach typical in
the early steps of stepped care (Burns, Kellett, & Donohoe, 2016). SC has grown in
terms of the frequency with which it is delivered in primary care. For example, in the
United Kingdom’s Improving Access to Psychological Therapies (IAPT) programme,
SC is the most commonly delivered psychoeducational group intervention delivered
within the early steps of the stepped care pathway (Delgadillo et al., 2016). A number
of criticisms have been raised about SC including the impersonal nature of the
approach, high dropout rates, lack of any idiosyncratic adjustment, and the approach
representing an overall disinvestment in one-to-one psychotherapies (Gaudiano,
2008).
The popularity of the SC approach means that it has been delivered across a wide
variety of contexts, but it is possible to observe some trendswithin these data. Firstly, SC is
an intervention that has been primarily delivered in primary care. The origins of the SC
programme lay in Jim White’s early example of using stepped care principles in
community and primary care contexts (Brown et al., 2006; White & Kennan, 1990), but
there are also examples of SC being delivered in prisons (Breese, Maunder,Waddell, Gray,
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&White, 2012). Secondly, the intervention has evolved from being primarily concerned
with the management of generalized anxiety (White, Keenan, & Brookes, 1992) to also
include, in more recent versions, the management of depressive mood (Delgadillo et al.,
2016). Therefore, SC is delivered for the commonly occurring and mild-to-moderate
mental health problems that are a feature of community and primary care settings, the
range of anxiety disorders, trauma, obsessive compulsive disorders, and depression
(Sundquist, Ohlsson, Sundquist, & Kendler, 2017). Thirdly, SC assumes poor stress
management is a common underlying process that serves to maintain various common
mental health problems. Fourthly, the vast majority of the SC evidence base evaluates
outcomes in routine practice and therefore uses practice-basedmethodologies that do not
feature diagnostic interviewing, randomization, treatment adherence monitoring, strict
inclusion/exclusion criteria, and independent assessment (Barkham, Hardy, & Mellor-
Clark, 2010). There are fewer examples therefore of applying randomized and controlled
methods of evaluation (see for a SC controlled example, Kitchiner et al., 2009). Therefore,
considerable uncertainty still exists as to the diagnostic status of SC participants.
Nevertheless, SC is now a widely available treatment option for patients with mild-to-
moderate anxiety and/or depression (Delgadillo et al., 2016), and therefore, an evaluation
of the evidence base is indicated to inform future commissioning and the organization of
service delivery. Therefore, the present study sought to provide a contemporary
quantitative synthesis of the current SC evidence base, by conducting a meta-analysis of
treatment outcomes and by also disaggregating and evaluating the impact of SC on
anxiety, depression, and global distress. The review sought to supplement the synthesized
quantitative outcomes with the corresponding numbers needed to treat (NNT)
information and to explore possible moderators of SC treatment effects. Secondary aims
were to appraise the durability of SC effectiveness and the relative effectiveness of SC (i.e.,
compare outcomes against other interventions, including one-to-one psychotherapies)
and to summarize the cross-study dropout rate.
Method
The systematic review and meta-analysis were registered on PROSPERO
(CRD42020173676) prior to conducting formal literature searches and is reported in
line with PRISMA guidelines (Moher et al., 2015).
Study selection
Firstly, a comprehensive and systematic electronic search was conducted to identify
literature published after the original conceptualization of the SC programme (White,
1995). The searches were modified for each of six databases: Web of Science, Scopus,
MEDLINE, PsycINFO, Google Scholar, and OpenGrey. Secondly, search terms (expanded
using alternative synonyms, and both US and UK spelling) for (a) cognitive behavioural
therapy, (b) large group psychoeducation, (c) stress control, (d) anxiety, and (e)
depression were combined using a mixture of MeSH, title, abstract, keywords, and text
word searches. Filters to treatment outcomes and human populations were applied. The
final searches were run on 20/04/2020. Thirdly, reference lists from the identified articles
weremanually searched to identify any additional studies. Fourthly, to address the issue of
potential publication bias, attemptsweremade to contact clinical services from across the
United Kingdom known to have delivered SC in order to gain access to the grey literature.
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Eligibility criteria
Articles were eligible for inclusion if they were a treatment outcome study that reported
pre- and post SC treatment scores (and follow-up scores if available) on a validated
outcome measure (i.e., means and standard deviations [SD]) for adults (16 years +).
Studies were included if they used either a randomized controlled trial (RCT), a non-
randomized controlled trial or an uncontrolled design, or were a service evaluation (i.e.,
grey literature). Only studies written in English were included. Unpublished dissertations
and conference papers were included. Inclusion in the primary meta-analysis required
that pre–post outcomeswere assessed using a validatedpsychometricmeasure of anxiety,
depression, or global distress. If sufficient statistical information to calculate effect sizes
(ES) was not available, corresponding authors of potentially eligible studies were
contacted via email and given 4 weeks to supply statistical information. For inclusion in
the secondary meta-analysis investigating controlled studies, eligible studies included a
comparator condition (i.e., passive or active control) and assessed outcomes in both
conditions at post-treatment (and if available at follow-up).
Outcomes
Primary and secondary analyses
The three outcomes of interest were anxiety, depression, and global distress. Where
studies reported multiple measures of one outcome (e.g., anxiety), the most common
measure used across all studies was chosen to ensure each study contributed only one ES
per outcome. Between-treatment comparisons assessed anxiety and depression out-
comes only, due to limited global distress outcome data, measured by any of the outcome
measures from the primary analysis at post-treatment outcome only.
Assessment of study quality
The Psychotherapy Outcome Study Methodology Rating Scale (POSMRS; Ost, 2008)
assessed methodological quality of the studies, due to this measure being capable of
assessing the quality of both randomized and non-randomized study designs. The tool
assesses study quality across 22 items, with each item scored across three freeholds:
0 = poor, 1 = fair, and 2 = good. POSMRS score ranges are categorized: poor quality
(<15), fair quality (15–30), and good quality (31–44). The primary author assessed all
included studies, with two raters also each assessing a subset of included studies. All
studies were therefore double-rated. Inter-rater agreement was assessed with Cohen’s
Kappa statistics (k), interpreted as .21–40 indicating fair agreement, .41–.60 as moderate
agreement, .61–.80 as substantial agreement, and .81–1.0 as almost perfect agreement
(Landis & Koch, 1977). There was substantial agreement between rater 1 and rater 2
(k = .62) and rater 1 and rater 3 (k = .75).
Data extraction
A bespoke data extraction tool was designed and piloted. Any issues were resolved
through consensus in the research team.Datawere extracted across the following criteria:
(a) intervention characteristics (recruitmentmethod, group sizes, andnumber of session),
(b) methodological characteristics (study design and study quality), (c) patient charac-
teristics (age, gender [% female], and presenting problems), and (d) outcomes (pre–post
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and post-follow-up means, SDs and dropout rates). Where data were available, outcomes
for anxiety, depression, and global psychological distress were extracted at pre–post
treatment and at follow-up.
Within- and between-group effect sizes, numbers needed to treat, and dropout
For the primary analyses, pre–post treatment effect sizes were calculated for anxiety,
depression, and global psychological distress. A separate effect size was calculated for
each of the outcome measures. Effect sizes were computed for the difference between
pre–post treatment by subtracting the pre-treatment mean from the post-treatment mean
and then dividing the result by the pre-treatment standard deviation. To be able to
calculate the variance (and therefore the standard error) of pre–post changes, which is
required for inverse-variance meta-analyses, the correlation between the pre–post scores
is required. The majority of included studies did not report the pre–post correlations.
Therefore, an imputed value of 0.6 was used based on recommendations informed by the
median within-group correlation extracted from 811 measures of pre–post clinical trial
arms (Balk, Early, Patel, Trikalinos, & Dahabreh, 2012). To account for any small study
sample biases, effect sizeswere converted toHedges g using the J correction (Wasserman,
Hedges, & Olkin, 1985). In the primary analysis, positive effect sizes were an index of
symptom improvement following treatment, whereas negative effect sizes were an index
of symptom deterioration. Effect sizes were interpreted according to Cohen’s criteria,
where 0.2 is considered as a small effect, 0.5 is considered a moderate effect, and 0.8 is
considered a large effect (Cohen, 1992).NNT is traditionally calculated from the inverse of
the absolute risk reduction (ARR), which is the amount of risk that is reduced by the
treatment studied, comparedwith those participants in an RCTwhowere allocated to the
control condition (Sedgwick, 2015). Because the SC evidence base is predominantly
drawn from uncontrolled practice-based studies, the NNT was calculated from the pre–
post effect size. As such, the NNT estimated the number of SC patients needed to be
treated in the large groups in order for one patient to experience symptomatic
improvements relative to their pre-treatment level of impairment (rather than relative to a
control group).
For the secondary analyses, pre–post control group effect sizes were calculated for
those studies that had used a control, active treatment, or wait-list trial design (i.e., all
comparators). These comparisons enabled an estimate of the relative effectiveness of SC.
Effect sizeswere calculated by using the difference between themean pre–post change in
the SC and comparators divided by the pooled pre-treatment SD to account for pre-
treatment group differences (Morris, 2008). Where SC was compared against more than
one comparator, the SC group sample size was divided by the number of treatment
comparators, so that patients were not includedmore than once in the analysis (Cochrane
Collaboration, 2011). To calculate the average dropout rate for SC, the dropout rate in the
original study was extracted and the mean and SD calculated.
Data synthesis and quality
Available data were synthesized using the Meta-Essentials workbooks (Suurmond, van
Rhee, & Hak, 2017) and the package ‘forestplot’ in R studio (version 1.2.5019). Pooled
effect sizes and 95% confidence intervals (CI) were computed using the inverse of the
variance to weight the effect. Due to the expected level of heterogeneity resulting from
differences between study types, a random effects model was used to account for within-
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and between-study variances. Within- and between-study heterogeneity was assessed
using the I2 statistic to indicate the percentage of variation, and the Q-statistic was used to
assess statistical significance. Higgins, Thompson, Deeks, and Altman’s (2003) criteria
were used to identify low (25%), moderate (50%), and high (75%) levels of study
heterogeneity.
All meta-analytic comparisons were assessed by two reviewers using the grading of
recommendation assessment, development, and evaluation (GRADE) tool (Dijkers,
2013). The quality of evidence for each comparison was evaluated across five aspects
of synthesis quality: limitations of the individual included studies, inconsistency in
treatment estimates, imprecision of treatment estimates, indirectness of treatment
estimates, and publication bias. Evidence quality (either high,moderate, low. or very low)
could be downgraded by one or more levels based on the perceived influence of
limitations on overall evidence quality.
Moderator and subgroup analyses
In the primary analysis, anticipated between-study heterogeneity was explored using pre-
specified subgroup and meta-regression analyses to explore variation in ES. Subgroup
analyses were used to explore three categorical variables: study type (RCT/non-RCT),
setting (primary care/community), and presenting problem (diagnosis/no diagnosis).
Meta-regression was used to explore three continuous variables: age, gender (% female),
and study quality. A minimum of 10 studies were required to conduct moderator analyses
(Cochrane Collaboration, 2011). To account for multiple testing, a Bonferroni correction
was applied to minimize type 1 errors. The alphawas adjusted to p < .017 (a = .05/3) for
between-subgroup differences and meta-regression beta coefficients.
Publication bias
Publication bias was assessed via visual inspection of funnel plot asymmetry. Egger’s
regression was used to statistically test for the presence of publication bias (Egger, Smith,
Schneider, & Minder, 1997). ‘Trim and Fill’ imputed any missing data and provided an
adjusted estimate effect, accounting for publication bias (Duval & Tweedie, 2000).
Results
Study selection
After the removal of duplicates, the search strategy produced a combined total of 70
articles (see Figure 1), including one record from unpublished grey literature searches
(Love, 2020). Title and abstract screening identified 25 articles for full-text review. Upon
review, six articleswere excluded leaving a total of 19 studieswhichmet inclusion criteria
for synthesis. All 19 studies were included in the primary pre–post and post-follow-up
quantitative synthesis, of which five studies (containing 11 comparisons) were also
included in the secondary comparator synthesis.
Study characteristics
Table 1 summarizes the characteristics of 19 included studies. SC is typically delivered
(k = 18) in public psychological health services, with one study set in a custodial setting.
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Studies were typically UK based (k = 16), with k = 2 studies set in Belgium and a single
study conducted inChina. In terms of design,k = 2were randomized control trials (RCTs)
and the remaining k = 17 studies were variations on practice-based evidence (PBE)
designs. These included controlled pre–post (k = 1) and controlled pre–post-follow-up
designs (k = 2) that included control conditions: single-group pre–post (k = 7) and pre–
post-follow-up designs (k = 6) and a service evaluation (k = 1). Overall, five studies
compared SC to a comparator/s (across 11 separate comparisons). SC was compared to
another psychological intervention in k = 4 studies containing seven separate compar-
isons (i.e., cognitive therapy, behaviour therapy, placebo-subconscious retraining,
individual CBT, individual psychodynamic interpersonal therapy, anxiety management,
andmindfulness-based cognitive therapy). SCwas compared to usual care in a single study
and wait-list or no treatment controls in k = 3 studies. Overall, risk of bias was fair, with
four studies classified as poor and14 studies classified as fair.Mean studyqualitywas 18.21
(SD = 4.48; maximum score 44). Risk of bias typically arose from studies not conducting
blinding, assessor training, treatment adherence, or therapist competence checks. The
two RCTs were of mixed methodological quality: Kitchener et al., (2009) scored 28 and
Figure 1. PRISMA diagram of included studies.
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Wong et al., (2016) scored 15. Ten studies evaluated SC outcomes at follow-up, with
follow-ups ranging between 1 and 24 months (mean = 6.5 months). Dropout rates
ranged between 0 and 63.6% (mean = 33.93%). The study sample size mean was 89.06
(SD = 52.87), and the average size of a SC group was 35.88 (SD = 21.99). Ages ranged
from 16 to 84 years (mean = 38.91), and presenting problems included anxiety disorder
(k = 9), depression (k = 2), panic disorder (k = 2), PTSD (k = 1), agoraphobia (k = 1),
OCD (k = 1), and stress (k = 1).
Meta-analysis of stress control outcomes
Meta-analytic comparisons were performed to aggregate the treatment effects of SC on (i)
anxiety, (ii) depression, and (iii) global distress symptoms from pre–post treatment and
from end of treatment to follow-up. GRADE assessments are reported for each meta-
analysis to denote the quality of evidence. All comparisons were mostly based on
practice-based studies with generally low quality of evidence. Across the primary pre–
post comparisons, studies were identified as having study limitations (due to lack of
control conditions increasing risk of confounding and poor follow-up), inconsistency in
estimates due to high levels of heterogeneity (large I2 values), and some evidence of
publication bias (for depression outcomes). As a result, the quality of evidence was
downgraded to very low quality. For the secondary between-group comparisons, studies
were identified as having some study limitations (lack of randomization to control
confounding and poor follow-up), some inconsistency from moderate heterogeneity, and
some imprecision evident in the wide confidence intervals of study estimates. The
between-group comparisons were therefore also downgraded to very low evidence
quality.
Effectiveness for anxiety at end of treatment and follow-up
The primary pre–post treatment meta-analysis was conducted on 21 comparisons
(extracted from 19 studies) of pre–post treatment anxiety outcomes, totalling N = 5597
participants. Figure 2 presents the pooled effect size (ES) showing moderate, significant
reductions in anxiety following SC (ES = 0.58; 95% CI 0.41 to 0.75; Z = 7.13; p < .001;
GRADE = very low). There was high and statistically significant between-study hetero-
geneity (I2 = 88%; Q = 168.02; p < .001). The anxiety NNT was 3.14. Funnel plot
symmetry (see Figure 5a) and a non-significant Egger’s regression suggested no significant
influence of publication bias for pre–post treatment anxiety outcomes (B = 0.57,
p = .988). Trim and fill imputation did not account for any missing studies, and as such,
the overall pooled treatment estimate (ES = 0.58; 95%CI 0.41 to 0.75) remained the same,
representing a moderate effect. End of treatment to follow-up data were provided in 12
comparisons (2 studies provided 2 groups), totalling N = 327 participants. There was a
significant, minimal effect size for anxiety at follow-up (see Figure 2), indicating that
anxiety symptoms minimally improved over follow -up time (ES = 0.14; 95% CI 0.00 to
0.28; Z = 2.14; p = .032; GRADE = very low). There was low-to-moderate, non-signifi-
cant heterogeneity (I2 = 36%; Q = 17.19; p = .102).
Effectiveness for depression at end of treatment and follow-up
The primary pre–post treatment meta-analysis was conducted on 21 comparisons (3
studies provided 2 groups) from N = 5538 participants providing pre–post
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treatment outcomes. Figure 3 presents the pooled effect size, showing moderate,
significant improvements in depression following SC (ES = 0.62; 95% CI 0.44 to
0.80; Z = 7.30; p < .001). There was significant, high between-study heterogeneity
detected (I2 = 84%; Q = 125.69; p < .001; GRADE = very low). The depression
NNT was 2.95. Asymmetry in the funnel plot (see Figure 5b) and a significant
Egger’s test (B = 0.57, p = .042) indicated some reporting bias for pre–post
depression outcomes. Trim and fill imputed data for three missing smaller studies,
which resulted in a small reduction in the SC effect size estimate (ES = 0.46; 95%
CI 0.23 to 0.69). End of treatment to follow-up data were provided in 12
comparisons (2 studies provided 2 groups), totalling N = 322 participants. There
was a non-significant, minimal effect size for depression at follow-up, indicating
that levels of depression symptoms were maintained over follow-up time
(ES = 0.02; 95% CI 0.08 to 0.13; Z = 0.52; p = .600; GRADE = very low). There
was minimal between-study heterogeneity (I2 = 0%; Q = 9.93; p = .536).
(a)
(b)
Figure 2. Forest plots of anxiety ES at a) pre–post treatment and b) end of treatment to follow-up.
Abbreviations defining the study identifiers of different independent subsamples for studies with more
than one effect size: G1 = group 1; G2 = group 2; MBS = mindfulness; body scan; PMR = progressive
muscle relaxation; GAD = generalized anxiety disorder; PD = panic disorder.
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Effect for global psychological distress at end of treatment and follow-up
The primary pre–post treatment meta-analysis was conducted on 15 comparisons (2
studies provided 2 groups) from N = 591 participants providing pre–post treatment
outcomes for global distress. Figure 4 presents the pooled effect size, showing large,
significant reductions in global psychological distress after SC (ES = 0.86; 95% CI 0.61 to
1.11; Z = 7.41; p < .001; GRADE = very low). There was significant between-study
heterogeneity (I2 = 87%; Q = 95.82; p < .001). The global psychological distress NNT
was 2.19. The global distress outcome funnel plot (see Figure 5c) was asymmetrical, but
Egger’s regression was not significant (B = 2.03, p = .098). Trim and fill imputed data
for onemissing smaller study with a small deterioration effect after SC, resulting in a small
reduction in the SC effect size estimate that still represented a large effect (ES = 0.82; 95%
CI 0.56 to 1.07). Taken together, these results suggest a small impact of publication bias in
the included studies. End of treatment to follow-up data were provided in 7 comparisons
(1 study provided 2 groups), totalling N = 209 participants. There was a non-significant,
(a)
(b)
Figure 3. Forest plots of depression ES at a) pre–post treatment and b) end of treatment to follow-up.
Abbreviations defining the study identifiers of different independent subsamples for studies with more
than one effect size: G1 = group 1; G2 = group 2; MBS = mindfulness body scan; PMR = progressive
muscle relaxation; GAD= generalized anxiety disorder; PD = panic disorder.
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minimal effect size for global distress symptoms at follow-up, indicating that improve-
ments in global distressweremaintained over follow-up time (ES = 0.08; 95% CI0.06 to
0.23; Z = 1.46; p = .145; GRADE = very low). There was non-significant between-study
heterogeneity (I2 = 0%; Q = 5.43; p = .490).
Moderator analyses
Meta-regression (see Table 2) and subgroup analyses (see Table 3) investigated moder-
ators of SC treatment effects by exploring heterogeneity in pre–post treatment anxiety,
depression, and global distress outcomes. Variations in treatment effects for anxiety,
depression, and global distress symptoms were not explained by differences in
participants’ age, gender, or study quality. No significant differences for anxiety,
depression, or global distresswere found based on study design orwhether participants in
(a)
(b)
Figure 4. Forest plots of global distress ES at a) pre–post treatment and b) end of treatment to follow-
up.375285012318900 Abbreviations defining the study identifiers of different independent subsamples
for studies with more than one effect size: PMR = progressive muscle relaxation; MBS = Mindfulness
body scan; G1 – group 1; G2 = group 2.
14 Neil Dolan et al.
Table 2. Meta-regression analyses of pre–post SC treatment outcomes
Outcome Variable No. of comparisons B-coefficient 95% CI SE p R2 (%)
Anxiety Mean age Years 14 0.01 0.01–0.04 0.01 .164 11.74
Gender % female 17 0.00 0.01–0.01 0.00 .995 0.00
Study quality (rating 0–44) 20 0.01 0.02–0.05 0.02 .795 4.69
Depression Mean Age Years 14 0.01 0.03–0.02 0.01 .656 0.74
Gender % female 19 0.00 0.00–0.01 0.00 .382 2.24
Study quality (rating 0–44) 20 0.00 0.04–0.03 0.01 .759 0.33
Global distress Mean Age Years 9 0.02 0.03–0.07 0.02 .416 9.34
Gender % female 14 0.00 0.01–0.01 0.00 .634 2.01
Study quality (rating 0–44) 14 0.00 0.04–0.05 0.02 .883 0.17
Note. k = number of comparisons; CI = confidence intervals; SE = standard error; R2 = percentage of variation explained.






studies had a diagnosis versus no diagnosis. Significantly larger effects were observed for
anxiety, depression, and global distress symptoms in studies that recruitedpatientswithin
primary care clinical settings compared to community settings (only the effect for anxiety
symptoms remained significant after adjusting the p value for multiple testing).
The effectiveness of stress control relative to control groups
Meta-analytic comparisons were conducted for depression and anxiety to compare the
aggregated effect of SC vs comparators at post-treatment only, as there was insufficient
longer term follow-updata in the studies. Eleven comparisons fromk = 5 studies, totalling
N = 560 participants, evaluated post-treatment SC anxiety outcomes with a comparator
(SC N = 157; comparator N = 403). The pooled effect size (see Figure 6) indicates a
minimal, non-significant treatment effect in favour of SC (ES = 0.12, 95%CI0.25 to 0.49,
Z = 0.70; p = .482; GRADE = very low). There was significant heterogeneity (I2=65%;
Q = 28.30, p = .002). Subgroup analysis indicated a minimal, non-significant effect in
favour of active controls compared to SCwithminimal heterogeneity (ES = 0.16, 95%CI
0.41 to 0.09, I2 = 14%,Q = 6.96, p = .325) and amoderate significant effect in favour of
SC compared to passive controls with minimal–to-low heterogeneity (ES = 0.68, 95% CI
0.33 to 1.03, I2 = 21%, Q = 3.78, p = .286).
Eleven comparisons from five studies, totalling N = 560 participants, evaluated post-
treatment depression outcomes against comparators (SC N = 157; comparator N = 403).
The pooled effect size (see Figure 6) indicates a minimal, non-significant treatment effect
in favour of SC (ES = 0.15, 95%CI0.24 to 0.54,Z = 0.84; p = .401;GRADE = very low).
There was a statistically significant and high level of heterogeneity (I2 = 71%; Q = 34.11,
p < .001). Subgroup analysis indicated a minimal-to-small, non-significant effect in favour
of active controls compared to SCwithminimal heterogeneity (ES = 0.19, 95%CI0.42
to 0.05, I2 = 2%,Q = 6.12, p = .410) and amoderate-to-large significant effect in favour of
Table 3. Subgroup analysis of pre–post SC treatment effect outcomes
Outcome Variable Subgroup K ES (g) 95% CI I2% p (between groups) R2 (%)
Anxiety Study type RCT 2 0.62 0.57–0.66 0 .782 0.31
PBE 19 0.58 0.40–0.76 89.24
Recruitment setting Primary care 13 0.69 0.46–0.92 89.79 .005** 24.82
Community 6 0.35 0.19–0.50 26.90
Presenting problem Diagnosis 11 0.59 0.45–0.73 46.63 .892 0.10
No reported diagnosis 10 0.57 0.28–0.85 93.81
Depression Study type RCT 2 0.60 0.36–0.84 16.64 .839 0.12
PBE 19 0.63 0.44–0.81 85.54
Recruitment setting Primary care 13 0.73 0.51–0.95 87.33 .046* 11.68
Community 6 0.43 0.14–0.72 63.85
Presenting problem Diagnosis 11 0.62 0.39–0.86 71.55 .953 0.01
No diagnosis 10 0.61 0.37–0.86 88.77
Global distress Study type RCT 1 0.64 0.25–1.04 – – –
PBE 14 0.87 0.63–1.12 87.54
Recruitment setting Primary care 7 1.06 0.75–1.36 84.13 .044* 23.99
Community 6 0.62 0.28–0.97 68.63
Presenting problem Diagnosis 5 0.94 0.61–1.26 73.30 .631 1.82
No diagnosis 10 0.82 0.51–1.13 89.56
Note. k = number of comparisons; ES (g) = Effect size hedge’s g; CI = confidence intervals; SE = stan-
dard error; R2 = percentage of variation explained.
*Significant at p < .05: *Significant at Bonferroni adjusted p < .0166 threshold for multiple testing.
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Figure 5. Funnel plots of pre–post effect sizes for a) anxiety, b) depression, and c) global distress.
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SC compared to passive controls with moderate heterogeneity (ES = 0.74, 95% CI 0.27 to
1.21, I2 = 54%,Q = 6.47,p = .091). Sensitivity analyses comparing the aggregated effects
of all eligible studies (reported as themain analyses)with the aggregated effectswhenonly
including studies that used a RCT design are reported in the Appendix S1.
Discussion
This review investigated the effectiveness of SC group-based psychoeducational
interventions on anxiety, depression, and global distress. The depression and anxiety
ES were comparable though slightly lower than the pre–post treatment ES reported in a
recent meta-analysis of practice-based evidence from the IAPT programme (Wakefield
et al., 2021), where SC has been widely implemented at a national level. The recruitment
(a)
(b)
Figure 6. Forest plots comparing anxiety and depression SC vs comparator ES at post-treatment.
Abbreviations defining the study identifiers that indicate the comparator condition for each independent
comparison with SC: CT = cognitive therapy; BT = behaviour therapy; SCR = subconscious retraining;
WL = wait-list; ICBT = individual cognitive behaviour therapy; I-PI = individual psychodynamic inter-
personal therapy; AM = anxiety management; MBCT = mindfulness-based cognitive therapy;
UC = usual care.
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setting (primary care- versus community-based recruitment) was the only moderating
factor of outcomes, such as that community samples tended tohave lower effect sizes. The
comparator analysis found a moderate-to-large effect favouring SC compared to passive
controls, but no significant difference between SC and active controls at post-treatment.
Although SC appears to have similar depression and anxiety outcomes to other
psychological interventions examined in controlled studies, these findings need be
considered in light of the high patient-to-therapist ratios that SC enables (White&Kennan,
1990).
The follow-up results generally demonstrate that treatment gains from SC were
maintained over time, and this is in line with previous single-study evidence demonstrat-
ing maintained improvements at 1-year (Van Daele, van Audenhove, Vansteenwegen,
Hermans, & Van der Bergh, 2013b) and 2-year follow-ups (White, 1998). In terms of
acceptability, the average dropout rate across SC studies (34%) appears comparable to
other group psychological interventions, as approximately 25–50% dropout from groups
in routine practice settings (Batch, 2018; Simon et al., 2012). Prior research indicates that
high socio-economic deprivation predicts dropout from SC groups (Burns et al., 2016;
Firth, Delgadillo, Kellett, & Lucock, 2020). The average size of a SC group was N = 38 in
the current review, suggesting the routine delivery of relatively large groups. The pre–
post treatment NNT was approximately three across all outcome measures. Hence, it
might be expected that around 12.6 people in a typical group of N = 38 SC participants
are likely to experience considerable symptomatic improvement relative to their pre-
treatment functioning. As such, SC represents a low-intensity psychoeducational
intervention that is clinically effective and organizationally efficient. When SC was
compared to seven active treatments, few significant differences were found, and so this
challenges criticisms that SC is merely a means of services managing waiting lists
(Gaudiano, 2008).
Limitations of the current review
The methodological quality rating tool used (POSMRS; Ost, 2008), whilst being selected
on the basis that it could rate both randomized and non-randomized study designs, tended
to assign low-quality ratings to practice-based studies and may therefore be less
appropriate for such designs compared to other tools that are designed to rate the quality
of uncontrolled observational studies. As the included studies were made up of mostly
practice-based evidence, this subsequently contributed to a lower quality rating of the
overall meta-analysis as indicated by the GRADE assessments. GRADE highlighted
additional issues with inconsistency in estimates and some evidence of publication bias
(for depression outcomes), so the conclusions that can be drawn from the results do have
some caveats. It is acknowledged that the screening of titles and abstracts was only
completed by one reviewer, potentially introducing bias into study selection. Further-
more, we were only able to access data from one unpublished study from routine service
evaluations, and it is possible that other SC data sources exist but were not successfully
obtained through our searches and communications with corresponding authors of
eligible studies.
The pre–post treatment ES analyses were limited, due to the need to account for the
correlation data that were often not reported and a lack of a randomized control
comparator. Treatment effects in uncontrolled studies cannot be fully attributed to SC, as
some of the outcomemay partially arise from spontaneous recovery or other such factors.
However, attempts were made to minimize theses biases in the form of imputing
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correlations in effect sizes and performing a preliminary comparison of between-group
effects to provide context. Some of the included studies had small study sample sizes
(especially for the between-group comparisons) which can produce inflated ES and result
in imprecise evaluations of between-study heterogeneity (IntHout, Ioannidis, Borm, &
Goeman, 2015). Such small study sample sizes are curious, as they appear in contrast to
the large group philosophy of the SC intervention. Moreover, moderator analyses were
subject to low power and inadequate subgroups, due to the low number of observations
for some variables to be able to detect reliable variation in effects (Guolo & Varin, 2017).
The comparator analysis was limited due to the small number of studies, of which not all
were randomized and as such the results cannot be considered robust (Bucher, Guyatt,
Griffith, & Walter, 1997).
Research implications
Nine key points are proposed to further enhance the SC evidence base: (a) consistent
primary outcomes need to be agreed by researchers to enable better comparisons across
services, (b) consistent reporting of attendance and dropout outcomes, (c) consistent
reporting on basic characteristics such as presenting symptoms, mean age, and gender,
(d) taking a measure of treatment adherence, (e) routinely following up SC completers
over the short and long term, (f) comparing SC outcomes against other bona fide
psychological interventions, (g) measuring patient preferences, (h) testing interventions
to reduce SCdropout (see Avishai, Oldham,Kellett, & Sheeran, 2018 for anRCTexample),
and (i) testing interventions to reduce the impact of socio-economic deprivation on
attendance and outcome.
Service implications
This review has indicated that SC is an effective group-based LI intervention, and
therefore, the manner in which the intervention is offered and integrated into services is
important to consider. In services that follow stepped care principles, the patient journey
starts with a LI intervention and only non-responsivity to that interventionwould indicate
that the patient requires a more intensive intervention (Bower & Gilbody, 2005).
However, failure of an intervention may be demoralizing in terms of seeking future
psychological care, and therefore, the decision to allocate to SC is important to consider.
Whilst the large group SC approach is normalizing through attendance (Kellett, Clarke, &
Matthews, 2007), it is clear through the acceptability data presented here that SC is not
effective nor acceptable for every patient. SC should only be routinely offered for those
presentingwithmild-to-moderate anxiety and depression, as that is what the intervention
was designed for and that is what the evidence base rests upon. The development of well-
designed, easy-to-understand, and clear patient information leaflets contrasting and
comparing LI interventions need to be made routinely available in order to enable
informed patient choice and to support patient preferences (Kellett et al., 2020).
Group psychoeducation is recommended in the National Institute for Health and Care
Excellence (NICE) guidelines for commonmental health problems (NICE, 2011a, 2011b).
Guidelines are limited to group psychoeducation for generalized anxiety disorder (GAD),
panic disorder, and, under certain limited circumstances, obsessive compulsive disorder
(NICE, 2011a). NICE guidelines for GAD specify inititaing CBT-based psychoeducational
groups with a group contract, that the six two-hour groups are facilitated by trained
professionals (in ratio of 1 facilitator to 12 patients) delivering presentations and
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encouraging participants to complete in-session exercises and also contain ’homework’
elements. Group-based psychoeducational interventions, computerized CBT, and one-to-
one guided self-help all need to be equal components of the LI offer in routine services,
thus offering choices to maximize acceptability and access to care for patients with
common mental disorders.
Conclusions
The present findings support earlier work suggesting that the SC large group psychoe-
ducational approach appears beneficial in reducing psychological distress (Delgadillo
et al., 2016). Although there were methodological limitations, the combined evidence
fromwithin-group and between-treatment analyses suggests that SC is effective in treating
psychological distress in primary care and community settings.Whilst patient preferences
for group approaches need to be considered, SC appears an acceptable, efficient, and
effective LI treatment option which should be offered at the early steps of stepped care
services for mild-to-moderate anxiety and depression. Further, more controlled evalua-
tions of SC would always be a welcome addition to the evidence base.
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